Biotech Late Stage Investors & VC Firms
360 firms in this list, with a median first check of $1M. 82 of them lead rounds. Generated from verified public data and updated continuously.
Infotech Ventures
BeijingSeed–Late Stage
TPB
San FranciscoSeed–Late Stage
6 people
Vision Creator
SeoulSeed–Late Stage
BSK Investment
SeoulSeed–Late Stage
14 people
Clarus Ventures
Menlo ParkPre-Seed–Late Stage
8 people
Axil Capital
TokyoSeed–Late Stage
7 people
ACORN BIOVENTURES
New YorkSeed–Late Stage
3 people
Centurium Capital
XiamenGrowth–Late Stage
3 people
Bering Capital
San FranciscoSeed–Late Stage
8 people
Boston Millennia Partners
BostonSeed–Late Stage$3M – $5M
8 people
Fletcher Spaght, Inc.
BostonLate Stage
8 people
Flying L Partners
Late Stage
5 people
Gore Range Capital
New YorkSeries A–Late Stage$500K – $5M
17 people
PBM Capital
CharlottesvilleSeries A–Late Stage
7 people
Percipient Capital
LondonSeed–Late Stage$1.3M – $6.3M
3 people
BioFrontier Partners, Inc.
TokyoSeries A–Late Stage$500K – $3M
11 people
Samara Asset Group
BirkirkaraPre-Seed–Late Stage
6 people
Soleus Capital
GreenwichLate Stage
2 people
INP Capital
VancouverSeed–Late Stage
6 people
Alium Capital
SydneySeed–Late Stage
5 people
Roadmap Capital Inc.
TorontoSeed–Late Stage
5 people
Brace Pharma
AtlantaLate Stage
3 people
Muirwoods Ventures
SeoulSeed–Late Stage
The Finnish Innovation Fund Sitra
HelsinkiSeed–Late Stage$108K
4 people
Related lists
Biotech Investors & VC Firms (2585)Biotech Seed Investors & VC Firms (2105)Late Stage Investors & VC Firms (1710)Biotech Series A Investors & VC Firms (1693)Biotech Investors & VC Firms in North America (1688)Biotech Investors & VC Firms in United States (1535)Biotech Investors & VC Firms in Europe (990)Biotech Pre-Seed Investors & VC Firms (987)Late Stage Investors & VC Firms in North America (915)Biotech Investors & VC Firms in Global (887)
Data sourced from public filings and firms' own websites — see our methodology.






























































